Being designated to protect other tissues, skin is the first and largest human body organ to be injured and for this reason, it is accredited with a high capacity for self-repairing. However, in the case of profound lesions or large surface loss, the natural wound healing process may be ineffective or insufficient, leading to detrimental and painful conditions that require repair adjuvants and tissue substitutes. In addition to the conventional wound care options, biodegradable polymers, both synthetic and biologic origin, are gaining increased importance for their high biocompatibility, biodegradation, and bioactive properties, such as antimicrobial, immunomodulatory, cell proliferative, and angiogenic. To create a microenvironment suitable for the healing process, a key property is the ability of a polymer to be spun into submicrometric fibers (e.g., via electrospinning), since they mimic the fibrous extracellular matrix and can support neo- tissue growth. A number of biodegradable polymers used in the biomedical sector comply with the definition of bio-based polymers (known also as biopolymers), which are recently being used in other industrial sectors for reducing the material and energy impact on the environment, as they are derived from renewable biological resources. In this review, after a description of the fundamental concepts of wound healing, with emphasis on advanced wound dressings, the recent developments of bio-based natural and synthetic electrospun structures for efficient wound healing applications are highlighted and discussed. This review aims to improve awareness on the use of bio-based polymers in medical devices.
Poly(lactic acid)(PLA) is an aliphatic polyester that can be derived from natural and renewable resources. Owing to favorable features, such as biocompatibility, biodegradability, good thermal and mechanical performance, and processability, PLA has been considered as one of the most promising biopolymers for biomedical applications. Particularly, electrospun PLA nanofibers with distinguishing characteristics, such as similarity to the extracellular matrix, large specific surface area and high porosity with small pore size and tunable mechanical properties for diverse applications, have recently given rise to advanced spillovers in the medical area. A variety of PLA-based nanofibrous structures have been explored for biomedical purposes, such as wound dressing, drug delivery systems, and tissue engineering scaffolds. This review highlights the recent advances in electrospinning of PLA-based structures for biomedical applications. It also gives a comprehensive discussion about the promising approaches suggested for optimizing the electrospun PLA nanofibrous structures towards the design of specific medical devices with appropriate physical, mechanical and biological functions.
Core‐shell‐structured polyvinyl alcohol (PVA)‐poly (lactic acid) (PLA) nanofibers combining the hydrophilic trait of PVA and the biocompatibility of PLA were produced using coaxial electrospinning. This allowed the incorporation of AgNO3 in the PVA core of the distinct fibers as shown through transmission electron microscopy (TEM) and Fourier transform infrared spectroscopy (FTIR). Scanning electron microscopy (SEM) showed relatively uniform and bead‐free fibers with smooth surfaces. Ag‐containing fibers show significantly decreased diameters compared with Ag‐free samples as a result of the increased conductivity of the spinning solutions with increasing amounts of AgNO3. In a postsynthetic treatment, the AgNO3 was reduced forming silver nanoparticles (Ag NPs). Ag NPs of 45 to 90 nm size were located in the PVA core but also on the surface of the core‐shell fibers and as individual, agglomerated, and polymer‐coated particles of 100‐200 nm. Powder X‐ray diffraction (PXRD), energy dispersive X‐ray spectroscopy (EDX), and UV‐vis absorption spectroscopy confirmed the increasing amounts of Ag in the core‐shell fibers when using increasing amounts of AgNO3 in the spinning solutions. The antibacterial activity of the nanofiber mats against two prokaryotes Escherichia coli (Gram‐negative) and Staphylococcus aureus (Gram‐positive) increased with increasing amounts of Ag, as expected and produces inhibition zones of 1 to 2 mm.
1 July 2017 in Journal of the Mechanical Behavior of Biomedical Materials